[Click e-Stock] "CUREXO Expected to Grow in Medical Robotics"

On December 3, Sangsangin Securities analyzed that CUREXO has entered a growth phase in the medical robotics sector.

Ha Taegi, a researcher at Sangsangin Securities, explained, "Among CUREXO's medical robots, CUVIS-joint is the core product," adding, "CUVIS-joint has a high export ratio."

He further stated, "There has been a clear increase in exports to India this year," and estimated, "The export volume of medical robots to India is expected to be around 6 billion KRW in the third quarter and about 7 billion KRW in the fourth quarter of this year."

He added, "In the fourth quarter of this year, exports to Japan are increasing, and commercial exports are also expected to occur in Taiwan, Vietnam, and Myanmar." He emphasized, "Looking at the overall status of medical robot exports, the figure is expected to rise from 10.3 billion KRW last year to 27.2 billion KRW this year."

He also estimated, "Annual medical robot sales for this year are expected to reach 35.8 billion KRW, an 84.5% increase compared to the previous year."

Researcher Ha stated, "The biggest long-term vision for medical robot exports is entry into the European and US markets," and analyzed, "There is a possibility that CUVIS-joint will receive the European CE MDR certification in the first quarter of next year." He continued, "CUREXO completed clinical trials for CUVIS-joint in the US and submitted an application for approval to the US Food and Drug Administration (FDA) in July this year." He expressed his expectations, saying, "If there are no special requests for supplementation after the application, approval is expected within one year."